Researchers find potential therapeutic target for controlling obesity

A new study from Mount Sinai School of Medicine has found that a cellular signaling pathway governs the differentiation of cells into fat tissue or smooth muscle, which lines the vascular system. Engaging this signaling pathway and its capacity to govern cell differentiation has important implications in preventing obesity and cardiovascular disease. The study is published in the June issue of Developmental Cell.

This research, by Philippe M. Soriano, PhD, Professor, Developmental and Regenerative Biology at Mount Sinai School of Medicine, and Lorin E. Olson, PhD, previously a postdoctoral fellow in the laboratory who is now an Assistant Member of the & Cancer Research Program at the Oklahoma Medical Research Foundation, is a novel in vivo study to evaluate the signaling activity of the Platelet Derived Growth Factor Receptor-beta (PDGFR-beta). The research team used mice that were genetically engineered to have elevated PDGFR signaling. They found that elevated PDGFRβ signaling inhibits differentiation of immature mesenchymal stem cells. These cells have the ability to give rise to multiple cell types in the organism, including fat cells and vascular smooth muscle.

"How mesenchymal cells are regulated within the body had been unclear until now. Our research is the first done in animals to show that PDGFR is a key regulator of cellular differentiation into fat cells or cells," said Dr. Soriano. "These data indicate that PDGFR-beta plays a critical role in determining their cellular fate, providing a new therapeutic target in preventing the onset of diseases like obesity."

The researchers caution, based on their previous research published in Developmental Cell, that some types of chronic activation of PDGFR receptors may result in tumor formation. Therefore, signaling events further in the differentiation process may be better therapeutic targets. More research is needed to better understand how PDGFR-beta regulates mesenchymal and the immune system's response to that activity to help identify treatments for cardiovascular and obesity-related diseases.

Provided by The Mount Sinai Hospital

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Tumor suppressor may attenuate fibrotic disease

Feb 17, 2009

New research reveals a critical cellular signaling pathway that is responsible for generating excess connective tissue in multiple organs, similar to what is seen in human patients with scleroderma. The study, published by ...

Cellular crosstalk linked to lung disease

Aug 18, 2009

Crosstalk between cells lining the lung (epithelial cells) and airway smooth muscle cells is important in lung development. However, it has also been shown to contribute to several lung diseases, including asthma and pulmonary ...

Growth factor hit by cancer drugs also protects heart

Jan 11, 2010

A growth factor that is a common target of cancer drugs also plays an important role in the heart's response to stress, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Journal of ...

Recommended for you

Small RNAs in blood may reveal heart injury

4 hours ago

(Medical Xpress)—Like clues to a crime, specific molecules in the body can hint at exposure to toxins, infectious agents or even trauma, and so help doctors determine whether and how to treat a patient. ...

Researchers uncover clues to flu's mechanisms

9 hours ago

A flu virus acts like a Trojan horse as it attacks and infects host cells. Scientists at Rice University and Baylor College of Medicine have acquired a clearer view of the well-hidden mechanism involved.

User comments